Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0032
ICR Reference No:
201104-0910-011
Status:
Historical Active
Previous ICR Reference No:
200803-0910-001
Agency/Subagency:
HHS/FDA
Agency Tracking No:
Title:
New Animal Drug Application, 21 CFR Part 514
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
06/27/2011
Retrieve Notice of Action (NOA)
Date Received in OIRA:
04/28/2011
Terms of Clearance:
In accordance with 5 CFR 1320, OMB approves this collection for a period of two years. FDA states that it is developing a method of electronic collection of this information but that no such method currently exists. Before resubmitting this ICR for extension, FDA should implement an electronic form of collection to reduce burden on the public.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
06/30/2013
36 Months From Approved
06/30/2011
Responses
1,517
0
1,412
Time Burden (Hours)
33,146
0
30,421
Cost Burden (Dollars)
0
0
0
Abstract:
This clearance submission is a consolidation of information collection activities associated with approval of new animal drugs. To gain approval to market an animal drug, the applicant must file a New Animal Drug Application containing data to support the safety and effectiveness of the drug, appropriate labeling, product manufacturing information, and where applicable, methods to determine residues of the drug in edible tissue from food producing animals; file a petition to obtain a waiver from labeling requirements for certain drugs intended for use in animal feed or drinking water.
Authorizing Statute(s):
US Code:
21 USC 512
US Code:
21 USC 379 j-11
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
76 FR 6798
03/08/2011
30-day Notice:
Federal Register Citation:
Citation Date:
76 FR 20684
04/13/2011
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
9
IC Title
Form No.
Form Name
514.1 and 514.6
356 V
Application for Approval of A New Animal Drug
514.1(b)(8) and 514.8(c)(1)
356 V
Application for Approval of A New Animal Drug
514.11
356 V
Application for Approval of A New Animal Drug
514.5(b)(d)(f)
356 V
Application for Approval of A New Animal Drug
514.8(b)
356 V
Application for Approval of A New Animal Drug
514.8(c)(1)
356 V
Application for Approval of A New Animal Drug
514.8(c)(2)(3)
356 V
Application for Approval of A New Animal Drug
558.5(i)
356 V
Application for Approval of A New Animal Drug
FDA FORM 356V
356 V
Application for Approval of A New Animal Drug
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
1,517
1,412
0
0
105
0
Annual Time Burden (Hours)
33,146
30,421
0
0
2,725
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Annual Cost to Federal Government:
$11,271,514
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Johnny Vilela 301 796-3792 juanmanuel.vilela@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
04/28/2011
An official website of the United States government
The .gov means it's official.
The site is secure.
